Kittel, M., Findeisen, P., Muth, M., Thiaucourt, M., Gerhards, C., Neumaier, M., & Haselmann, V. (2021). Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys anti-SARS-CoV-2 immunoassay. International journal of infectious diseases, 105, . https://doi.org/10.1016/j.ijid.2021.02.024
Chicago Style (17th ed.) CitationKittel, Maximilian, Peter Findeisen, Maria-Christina Muth, Margot Thiaucourt, Catharina Gerhards, Michael Neumaier, and Verena Haselmann. "Specificity Testing by Point Prevalence as a Simple Assessment Strategy Using the Roche Elecsys Anti-SARS-CoV-2 Immunoassay." International Journal of Infectious Diseases 105 (2021). https://doi.org/10.1016/j.ijid.2021.02.024.
MLA (9th ed.) CitationKittel, Maximilian, et al. "Specificity Testing by Point Prevalence as a Simple Assessment Strategy Using the Roche Elecsys Anti-SARS-CoV-2 Immunoassay." International Journal of Infectious Diseases, vol. 105, 2021, https://doi.org/10.1016/j.ijid.2021.02.024.